Unique ID issued by UMIN | UMIN000048009 |
---|---|
Receipt number | R000054723 |
Scientific Title | Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder |
Date of disclosure of the study information | 2022/06/09 |
Last modified on | 2025/05/22 13:17:27 |
Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder
Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder
Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder
Randomized Controlled Trial of Videoconference delivered Cognitive Behavioral Therapy for Adults with Attention Deficit/Hyperactivity Disorder
Japan |
Attention Deficit/Hyperactivity Disorder
Psychiatry |
Others
NO
To verify that the Videoconference delivered Cognitive Behavioral Therapy for Adults with ADHD(CBT) is significantly more effective than a wait-list control (WLC).
Safety,Efficacy
Exploratory
Others
Phase II
the ADHD-RS-IV with Adult Prompts Japanese Version
Pre test
Post test
Conners' Adult ADHD Rating Scale
ADHD Symptoms Checklist
Patient Health Questionnaire-9 (PHQ-9)
Generalized Anxiety Disorder-7 (GAD-7)
Euro Qol 5 Dimension 5 level (EQ-5D-5L)
Sheehan Disability Scale(SDISS)
Rosenberg's Self-esteem Scale
Pre test
Post test
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
No treatment
YES
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Maneuver |
Video-conference based cognitive behavioral therapy for ADHD(12weeks)
Wait-list control (12weeks)
18 | years-old | <= |
65 | years-old | >= |
Male and Female
(1)Patients who meet the diagnostic criteria in the DSM-5 based on the CAADID (Conners' Adult ADHD Diagnostic Interview for DSM-IV).
(2)Male or Female, aged 18-65 years
(3) Patients is willing and able to give informed consent for participation in the study.
(4)Able to communicate fluently and participate cognitive behavioral therapy sessions in Japanese
(5)Patients with regular medical care for A D H D at least once every 8 weeks
(6)Patients who have been stabilized on medications for ADHD
(7) Able to use the Internet and computer
(1) Diagnosis of schizophrenia, conduct disorders, organic disorder, mental retardation, neurocognitive disorder (dementia), autistic spectrum disorder, or substance abuse/substance dependence disorder
(2) Active suicidal ideation
(3) Unable to communicate fluently in Japanese.
(4) Patients who have received cognitive behavioral therapy in the past
(5) Other reasons inadequate for study participation
30
1st name | Eiji |
Middle name | |
Last name | Shimizu |
Graduate School of Medicine Chiba University
Research Center for Child Mental Development, Department of Cognitive Behavioral Physiology
260-8670
1-8-1 Inohana,Chuouku,Chiba,Japan
043-226-2027
eiji@faculty.chiba-u.jp
1st name | Aiko |
Middle name | |
Last name | Eto |
Graduate School of Medicine Chiba University
Department of Cognitive Behavioral Physiology
260-8670
1-8-1 Inohana,Chuouku,Chiba,Japan
043-226-2027
21fd0129@student.gs.chiba-u.jp
Research Center for Child Mental Development,Department of Cognitive Behavioral Physiology
Chiba University
Other
Chiba university certified clinical research board
1-8-1 Inohana,Chuouku,Chiba,Japan
043-222-7171
hsp-chibacrc@chiba-u.jp
NO
2022 | Year | 06 | Month | 09 | Day |
Unpublished
Completed
2022 | Year | 06 | Month | 01 | Day |
2022 | Year | 09 | Month | 22 | Day |
2022 | Year | 07 | Month | 01 | Day |
2024 | Year | 08 | Month | 31 | Day |
2022 | Year | 06 | Month | 09 | Day |
2025 | Year | 05 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054723